If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Related content
Volume 9, Number 6, December 2010

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Commentary
pp. 667-667(1)
Authors: Arias-Carrion, Oscar; Stamelou, Maria

Favourites:Add to Favourites
Favourites:Add to Favourites

Development of Novel Genomic Blood Biomarkers for Neurodegenerative Diseases
pp. 669-678(10)
Authors: Borovecki, Fran; Habek, Mario

Favourites:Add to Favourites

Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases
pp. 679-692(14)
Authors: J.S. Viana, Ricardo; B. Fonseca, Maria; M. Ramalho, Rita; F. Nunes, Ana; M.P. Rodrigues, Cecilia

Favourites:Add to Favourites

Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders
pp. 701-719(19)
Authors: Xilouri, Maria; Stefanis, Leonidas

Favourites:Add to Favourites

Wnt Signalling is a Relevant Pathway Contributing to Amyloid Beta-Peptide-Mediated Neuropathology in Alzheimer's Disease
pp. 720-726(7)
Authors: A.B. da Cruz e Silva, Odete; Gabriela Henriques, Ana; Catarina Timoteo Santos Domingues, Sara; F. da Cruz e Silva, Edgar

Favourites:Add to Favourites

Tau Phosphorylation and Aggregation as a Therapeutic Target in Tauopathies
pp. 727-740(14)
Authors: Badiola, Nahuai; Suarez-Calvet, Marc; Lleo, Alberto

Favourites:Add to Favourites

Molecular Chaperones as Rational Drug Targets for Parkinson's Disease Therapeutics
pp. 741-753(13)
Authors: K. Kalia, S.; V. Kalia, L.; J. McLean, P.

Favourites:Add to Favourites

Neurotrophic Factors as a Protective Strategy in Parkinson's Disease
pp. 754-763(10)
Authors: Jose Diogenes, Maria; Fleming Outeiro, Tiago

Favourites:Add to Favourites

Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis
pp. 764-778(15)
Authors: Costa, Julia; Gomes, Catarina; de Carvalho, Mamede

Favourites:Add to Favourites

Genetic Determinants of Amyotrophic Lateral Sclerosis as Therapeutic Targets
pp. 779-790(12)
Authors: A. Bosco, Daryl; E. Landers, John

Favourites:Add to Favourites

Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntington's Disease
pp. 791-800(10)
Authors: A. Thevandavakkam, Mathuravani; Schwarcz, Robert; J. Muchowski, Paul; Giorgini, Flaviano

Favourites:Add to Favourites

Schwann Cells as a Therapeutic Target for Peripheral Neuropathies
pp. 801-806(6)
Authors: C. Lehmann, Helmar; Hoke, Ahmet

Favourites:Add to Favourites

Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?
pp. 807-812(6)
Authors: De Filippis, Daniele; Cipriano, Mariateresa; Esposito, Giuseppe; Scuderi, Caterina; Steardo, Luca; Iuvone, Teresa

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more